CAS 890128-81-1

6-((6-(Hydroxymethyl)pyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide

CAS: 890128-81-1

Formel: C₂₃H₁₆F₃N₃O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 439.3866

Ref: IN-DA01EB1C

BFH772

CAS: 890128-81-1

BFH772

Formel: C₂₃H₁₆F₃N₃O₃

Reinheit: ≥95%

Molekulargewicht: 439.39

Ref: 54-BUP09997

BFH772

CAS: 890128-81-1

BFH772, a BAW2881 analogue, selectively inhibits VEGFR2 (IC50: 3 nM) and blocks RET, PDGFR, KIT phosphorylation (IC50: 30-160 nM).

Formel: C₂₃H₁₆F₃N₃O₃

Reinheit: 97.71% - 99.89%

Farbe und Form: Solid

Molekulargewicht: 439.39

Ref: TM-T3599

BFH772

CAS: 890128-81-1

6-((6-(Hydroxymethyl)pyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide

Formel: C₂₃H₁₆F₃N₃O₃

Reinheit: 98%

Molekulargewicht: 439.39

Ref: IN-DG764785

BFH772

CAS: 890128-81-1

Reinheit: 98%

Molekulargewicht: 439.3940125

Ref: 10-F870347

BFH772

CAS: 890128-81-1

BFH772 is a monoclonal antibody that binds to the IL-17 receptor. It has been shown to be effective in treating autoimmune diseases such as psoriasis, rheumatoid arthritis, and Crohn's disease. BFH772 also inhibits the binding of IL-17 to the IL-17 receptor, preventing activation of them. This drug is being investigated for use in treating cancer and choroidal neovascularization.

Formel: C₂₃H₁₆F₃N₃O₃

Reinheit: Min. 95%

Molekulargewicht: 439.39 g/mol

Ref: 3D-QKB12881